Field note · September 2026

A warning letter is a verdict on the fix, not the fault

Most people read an FDA warning letter as a list of things that went wrong. A contaminated batch, a skipped test, a room that was never properly validated. They assume the job is to fix the items on the list.

The FDA reads it differently. By the time a letter is issued, an inspector has already seen the problem, the company has already responded, and the agency has decided that response was not good enough. The letter is less about the defect than about what the company did next.

The defect got them inspected. The weak investigation got them the letter.

That is why the same phrases keep appearing: root cause not identified, corrective action not effective, the same failure recurring. Fixing the one contaminated room does not close the letter. Rebuilding the system that should have caught it does.

So the company that just received one does not need a pair of hands. It needs someone who has rebuilt a quality system under the agency's eye before, and it needs them before the next inspection, not after. That operator exists. The hard part is putting them in the room in the same week.

— Stephen Anindo routes triggered B2B companies to the operators built for that moment.